Mahmoud Ramadan mohamed Elkazzaz
2 clinical trials · Sponsor
◉ Watch Mahmoud Ramadan mohamed Elkazzaz
| Record | Firm | Date |
|---|---|---|
| CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients (NCT04990557) | Mahmoud Ramadan mohamed Elkazzaz | 2021-08-01 |
| Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. (NCT05016349) | Mahmoud Ramadan mohamed Elkazzaz | 2021-08-01 |
Track Mahmoud Ramadan mohamed Elkazzaz automatically
Every clearance here is in the API, with alerts when new ones post.